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Abstract
Objectives—Opioid pain reliever (OPR) prescribing at Emergency Department (ED) discharge 
has increased in the past decade but specific prescription details are lacking. Prior ED OPR 
prescribing estimates relied on national survey extrapolation or prescription databases. The main 
goal of this study was to utilize a research consortium to analyze the characteristics of patients and 
opioid prescriptions using a national sample of ED patients. We also aimed to examine the 
indications for OPR prescribing, characteristics of opioids prescribed both in the ED and at the 
time of discharge, and characteristics of patients who received OPRs compared with those who did 
not.
Methods—This observational, multi-centered, retrospective cohort study assessed OPR 
prescribing to consecutive patients presenting to the consortium EDs during 1 week in October 
2012. The consortium study sites consisted of 19 EDs representing 1.4 million annual visits, 
varied geographically, and were predominantly academic centers. Medical records of all patients 
aged 18-90 years discharged with an OPR (excluding tramadol) were individually abstracted via 
standardized chart review by investigators for detailed analysis. Descriptive statistics were 
generated.
Results—During the study week, 27,516 patient visits were evaluated in the consortium EDs. 
19,321 (70.2%) were discharged and 3,284 patients (11.9% of all patients and 17.0% of 
discharged patients) received an OPR prescription. For those prescribed an OPR, mean age was 
41.1 (SD 14.7) years and 1,694 (51.6%) were female. Mean initial pain score was 7.7 (SD 2.4). 
The most common diagnoses associated with OPR prescribing were back pain (10.2%), abdominal 
pain (10.1%), and extremity fracture (7.1%) or sprain (6.5%). The most common OPRs prescribed 
were oxycodone (52.3%), hydrocodone (40.9%) and codeine (4.8%). >99% were immediate 
release, 90.0% were combination preparations, and the mean and median number of pills was 16.6 
(SD 7.6) and 15 (IQR=12-20) respectively.
Conclusion—In a study of ED patients treated over a single week across the country, 17% of 
discharged patients were prescribed OPRs. The majority of the prescriptions had small pill counts 
and almost exclusively immediate release formulations.
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Introduction
Background
Pain is the most common reason for an emergency department (ED) visit; almost two-thirds 
of patients seeking ED care do so for acute pain or acute exacerbations of chronic pain (1, 
2). Emergency physicians frequently treat pain with opioid pain relievers (OPRs) (3). 
Unfortunately, opioid misuse, addiction, overdose and diversion have reached epidemic 
proportions in the United States (4). The contribution of ED prescribing to problematic 
opioid use is not clearly defined. Also, the rate of ED opioid prescribing and the attributes of 
ED opioid prescriptions have not been directly studied on a large scale.
Importance
Opioid pain relievers are an accepted treatment for the outpatient management in patients 
with moderate to severe acute pain (5). ED providers care for patients with a spectrum of 
pain severity and etiologies, and nationally emergency physicians are among the most 
frequent prescribers of OPRs in patients under age 40 (6). A recent study found that about 
one-third of all ED patients receive an opioid either administered in the ED or prescribed at 
discharge, up from 21% in a span of 10 years (7). Prescribing behavior is complicated by the 
nature of emergency care, which is often provided without the benefit of an established 
patient-doctor relationship and in an environment characterized by limited time and 
resources.
Goals of This Investigation
This study sought to describe the characteristics of OPR prescriptions from a cluster of 
consecutive visits in a one-week period across a large national sample of ED patients. 
Additionally, we sought to examine the indications for OPR prescribing, doses provided 
both in the ED and prescribed at the time of discharge, and characteristics of those patients 
who received OPRs compared to other patients evaluated in the ED during this time period.
Materials and Methods
Study Design and Setting
This was a retrospective cohort study of consecutive ED visits in a one-week period during 
October 2012. The 19 EDs participating in the study consortium were geographically 
distributed throughout the United States and were primarily academic (16/19) (Appendix 1). 
Annual ED census ranged from 42,000 to 230,000 (median 80,000), and in total represented 
approximately 1.4 million visits per year. Based on a small sample of hospital data, we had 
hypothesized that approximately 10-15% of discharged patients in our sample would receive 
an opioid prescription. Institutional Review Board approval was obtained at each site.
Selection of Participants
Patients aged 18-90 years who presented to the participating EDs between 12:01 am on 
October 15, 2012 and 11:59 pm on October 21, 2012 were eligible. Each site utilized an 
electronic medical record from which prescription data could be extracted automatically and 
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patient records could be evaluated by the site investigators. Each patient discharged with an 
OPR prescription underwent a manual medical record review.
Methods of Measurement
A query for all ED visits during the study period was generated by a site investigator and the 
following information was obtained: patient age, gender, insurance status, race/ethnicity, 
weekday (Monday 12:01 am-Friday 11:59 pm) or weekend (Saturday 12:00am-Sunday 
11:59pm) arrival, emergency severity index (ESI) triage level, first documented pain score 
(0-10), chief complaint, disposition (discharge from ED or other), discharge diagnosis, and a 
determination if an OPR prescription was given at discharge for the treatment of pain. OPR 
prescriptions were defined as any OPR prescription provided for a painful condition (e.g. 
oxycodone, hydrocodone, hydromorphone, codeine). Cases were excluded if an opioid was 
specifically prescribed for cough suppression. Tramadol was excluded because it is 
considered a less potent opioid and was not a scheduled medication at the time of the study.
ED records of the patients discharged with an OPR prescription underwent a manual chart 
abstraction by an investigator. Investigators entered information in to a structured data 
collection tool with an explicit protocol, defined variables (usually from a dropdown box if 
categorical) with a standardized abstraction instrument. There was no formal abstraction 
training or blinding to the outcome. Each site investigator was responsible for training and 
data fidelity at their individual site. The following information was collected in a de-
identified fashion and transferred to a centralized REDCap (8) database: 1) chief complaint, 
2) patient-reported home analgesic medications, 3) allergies to non-opioid pain medications, 
4) opioid medications, total doses, and route given in the ED, 5) other analgesics given in 
the ED, 6) primary discharge diagnosis, 7) pain scores at arrival and discharge, 8) opioid 
pain reliever medications, dose and quantity prescribed at discharge, 9) other analgesic 
medications prescribed at discharge, 10) characteristics of the primary caregiver in the ED 
(Appendix 2).
Primary Data Analysis
Summary data regarding the overall ED population were entered into Microsoft Excel 
(Microsoft Corp., Redmond, WA) and analyzed using SAS and JMP (both SAS Institute 
Inc., Cary, NC). The primary outcome of interest was the provision of a prescription for an 
OPR (including specific drug, dosage, and quantity dispensed) in patients discharged from 
the ED. Descriptive statistics were utilized for this purpose. Characteristics of prescriptions 
stratified by provider type were also evaluated and compared with the chi-squared test.
Results
Overall, there were 27,516 total patient visits at the 19 participating hospital sites during the 
study week. 19,321 patients (70.2%) were discharged, and 3,284 patients (11.9% of all 
patients and 17.0% of discharged patients) received an OPR prescription for the purpose of 
treating pain. Detailed characteristics of the 3,284 patients discharged with an opioid 
prescription compared with discharged patients who did not receive an opioid prescription 
are displayed in Table 1. The mean age of these patients was 41.1 (SD 14.7) years, range 
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18-90 years. A total of 900 (27.4%) reported prior use of analgesics at home: 434 (13.2%) 
used nonsteroidal anti-inflammatory medications (NSAIDs), 382 (11.6%) used OPRs and 
167 (5.1%) used acetaminophen. Medication allergies were reported by 975 (29.7%) of 
patients, and 270 (8.2% overall/28% of those reporting medication allergy) specifically 
reported allergies to non-OPRs.
The top ten chief complaints and discharge diagnoses are demonstrated in Table 2. Of 
patients prescribed an OPR at discharge, 2321 (70.7%) also received an opioid in the ED. 
The most common OPRs given while in the ED were: oxycodone 49.2% (n=1142), 
morphine 27.6% (n=640), hydrocodone 26.5% (n=614) and hydromorphone 17.9% (n=416). 
The total is greater than 100% because 524 patients (22.6% of those given an OPR while in 
the ED) were given more than one type of OPR. Initial pain scores (possible response range 
0-10) were recorded for 3004 (91.5%) patients. The mean initial pain score was 7.7 (95% CI 
7.7-7.8, range 0-10). Discharge pain scores were recorded for 1761 (53.6%) patients, and the 
mean was 4.4 (95% CI 4.3-4.6, range 0-10).
Prescriptions for OPRs, including dosages, are displayed in Table 3. Combination 
medications (e.g. those containing an OPR plus acetaminophen) accounted for 90.0% 
(n=2957) of OPR prescriptions. Sustained release products were only given to 11 (0.3%) 
patients. In addition, there were three prescriptions for methadone and one for a fentanyl 
patch. The number of pills per prescription was available for 3,110 (94.7%) of the 
prescriptions (volumes of suspension medications were not included in this analysis). The 
mean number of pills per prescription was 16.6 (95% CI 16.4-16.9) and the median was 15 
(IQR 12-20), with a range 2-100 pills (Figure 1).
We compared OPR prescribing when a physician was involved in the management with 
those patients primarily cared for by an advanced practice clinician (i.e. a nurse practitioner 
(NP) or physician assistant (PA)). Specifically for oxycodone and hydrocodone 
prescriptions, cases involving attending physicians were more often prescribed oxycodone 
than hydrocodone (OR 1.3 95% CI (1.1-1.5). However, for these two medications there was 
no difference in average pills per prescription given by attending physicians compared with 
NP/PA (mean 16.8 (95% CI 16.5-17.1) vs. 16.4 (95% CI 15.9-16.8) respectively). Table 4 
demonstrates the characteristics of ED patients who were discharged during the data 
collection period with and without an OPR prescription.
Limitations
Our data provides a snapshot of prescribing across several academic institutions during a 
one-week sample and may not reflect prescribing throughout the spectrum of hospitals, 
settings, and time periods. To address these threats to external validity we included 
geographically diverse centers. A majority of the sites (16/19) were academic, limiting the 
application of our findings to non-academic sites. We used seven consecutive days of data, 
and specifically chose a week with no holidays to avoid any possible selection bias, although 
the potential for seasonal variation remains. The generalizability of our sample is supported 
by the similarity to the findings from another study using nationally representative data sets 
(7).
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The retrospective, observational design of our study does not assess the reason OPRs were 
prescribed in some cases and not in others or why the range of pills per prescription was so 
large. Our focus was to describe patients who received an OPR prescription and therefore 
did not manually analyze extensive data about the “control” group of patients that did not 
receive an opioid for pain (e.g. pain scores) or provider characteristics. This limits some of 
the direct comparisons that can be made between these patient groups.
The greatest threat to the internal validity of our findings is the limitations of data collection 
and chart reviews. Researchers were based at each site; however, due to the size of the study 
and fact that many sites had only one investigator, we were unable to blind them to the 
outcome, train the abstractors or evaluate the abstraction (either the electronic record query 
or the specific standardized manual data abstraction) to assess agreement or accuracy of 
abstraction. However, the primary outcome (percentage of patients who received an OPR at 
discharge) was based on a controlled substance prescription in the computerized abstraction, 
and therefore less affected by subjective abstraction. As with any record review, inadequate 
or incorrect documentation could provide misleading results. Furthermore, it is possible that 
some of the data points, including home use of pain medications and allergies to non-opioids 
were provided incorrectly by the patient. However, this is likely not the case for the OPR 
prescription information, as there was computer order entry prescribing at all sites and this 
was not extracted manually from the clinical note.
Discussion
Opioid abuse and overdose have reached epidemic proportions in the United States, and 
recent attention has been focused on ED OPR prescribing guidelines and prescription drug 
monitoring programs (PDMPs) to potentially decrease diversion and reduce overdose rates 
(5, 9, 10, 11, 12). Despite these interventions, little is known about actual prescribing 
behaviors of emergency providers. Our results using individual record abstraction reinforce 
the findings of prior studies that relied on extrapolation from large databases.
Others evaluated prescriptions from approximately half of the retail pharmacies as a 
function of physician specialty in 2009 (6). Of the 79.5 million opioid prescriptions studied, 
emergency physicians were among the top 5 prescribers for all patients from age 0 to 39 
years. This study did not describe the number of pills per prescription or how specialty type 
was determined, particularly in cases where a rotating resident or specialist other than an 
emergency physician may have been working in an ED.
Another study used the National Hospital Ambulatory Medical Care Survey (NHAMCS) 
data to detect 10 year trends in OPR prescribing from EDs (7). NHAMCS is a publicly 
available dataset that allows estimates about ED services based on a random sample of 
visits. The authors reported that, at discharge in 2010, 9.1% of patients were discharged with 
hydrocodone, 3.9% with oxycodone and 0.8% with codeine. Numbers for hydromorphone, 
morphine and meperidine were not reported, nor were the number of pills per prescription. 
Although used to estimate trends, the NHACMS sampling validity is often criticized 
(13-17).
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We observed than more than 1 in every 6 patients discharged from the ED received an OPR, 
a finding not surprising given the magnitude of ED visits for pain (1, 2). The most common 
diagnosis was musculoskeletal back pain, followed by abdominal pain and then extremity 
fractures and sprains. Prescriptions for abdominal and back pain were also common in a 
statewide analysis of ED OPR prescriptions in Colorado (18).
In our cohort, the most common OPR prescribed (90%) was an immediate release 
combination product with acetaminophen, either oxycodone-acetaminophen or 
hydrocodoneacetaminophen. Of all prescriptions, oxycodone was the most common 
followed by hydrocodone. These observations are consistent with other prior research (19).
Almost all OPR prescriptions were for immediate release (99%) rather than long acting, 
patches or extended release medications. This near absence of prescribing extended-release 
or long-acting OPRs is consistent with most recommendations and reflects well on ED safe 
opioid prescribing principles for acute pain in this cohort. Another recent study also 
demonstrated that prescriptions originating from the ED were significantly less likely to be 
high dose or large quantity when compared to those originating from office-based practices 
(0.26% vs. 2.62%; P < .001) (20). Overall, it suggests that emergency prescribers are not 
initiating/refilling new prescriptions for these higher dose, higher risk drugs. Finally, it is 
interesting to evaluate the number of pills prescribed by emergency practitioners. In our 
study, the median number of pills dispensed was 15, consistent with most prescribing 
guidelines that recommend a maximum 3-5 day course of these medications from the ED (9, 
21, 22, 23). However, as noted in the limitations, our sample included primarily academic 
institutions and these results may not be fairly extrapolated to other hospital types.
There are several strengths to our study when compared to previous work in this area. We 
performed a structured chart review with individual prescription level data. Thus our study 
yields more clarity about current ED opioid prescribing. The use of multiple, geographically 
diverse, sites improves the external validity of our data and conclusions. We used data 
abstracted by reviewers at their own institutions, potentially enhancing the insights into 
prescribing and other chart findings.
In conclusion, we noted OPR prescriptions in 17% of discharged ED patients, with pill 
counts small and almost exclusively immediate release. These data can inform future opioid 
prescribing interventions.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Histogram demonstrating the number of pills per prescription given to patients (n=3110) at 
discharge. The figure includes an outlier box plot (right) and fitted normal distribution line 
(solid line overlying histogram).
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Table 1
Descriptive statistics of patients discharged from the ED with and without opioid pain relievers (OPRs)
Receiving OPRs Not receiving OPRs Total
N % (95% CI) N % (95% CI) N % (95% CI)
Age
    18-34 1289 39.3 (37.6-40.9) 6624 41.3 (40.5-42.1) 7913 41.0 (40.3-41.7)
    35-49 1023 31.2 (29.6-32.8) 4306 26.9 (26.2-27.5) 5329 27.6 (27.0-28.2)
    50-64 756 23.0 (21.6-24.5) 3364 21.0 (20.4-21.6) 4120 21.3 (20.8-22.0)
    65+ 216 6.6 (5.8-7.5) 1739 10.8 (10.4-11.3) 1955 10.1 (9.7-10.6)
    Missing 0 4 0.03 (0.00-0.06) 4 0.02 (0.00-0.05)
Gender
    Female 1694 51.6 (49.9-53.3) 8508 53.1 (52.3-53.8) 10202 52.8 (52.1-53.5)
    Male 1590 48.4 (46.7-50.1) 7456 46.5 (45.7-47.3) 9046 46.8 (46.1-47.5)
    Missing 0 73 0.5 (0.4-0.6) 73 0.4 (0.3-0.5)
Geographic Region
    Northeast 1633 49.7 (48.0-51.4) 9413 58.7 (57.9-59.5) 11046 57.2 (56.5-57.9)
    West 1046 31.9 (30.3-33.5) 3230 20.1 (19.5-20.8) 4276 22.1 (21.6-22.7)
    South 417 12.7 (11.6-13.9) 1811 11.3 (10.8-11.8) 2228 11.5 (11.1-12.0)
    Midwest 188 5.7 (5.0-6.6) 1583 9.9 (9.4-10.3) 1771 9.2 (8.8-9.6)
Race/Ethnicity
    White 971 29.6 (28.0-31.2) 4517 28.2 (27.5-28.0) 5488 28.4 (27.8-29.0)
    Black 531 16.2 (14.9-17.5) 3307 20.6 (20.0-21.3) 3838 19.9 (19.3-20.4)
    Hispanic 283 8.6 (7.7-9.6) 1342 8.4 (7.9-8.8) 1625 8.4 (8.0-8.8)
    Asian 58 1.8 (1.4-2.3) 413 2.6 (2.3-2.8) 471 2.4 (2.2-2.7)
    Missing/Other 1441 43.9 (32.2-45.6) 6458 40.3 (39.5-41.0) 7899 40.9 (40.2-41.6)
Weekend
    Weekday 2102 64.0 (62.4-65.6) 10976 68.4 (67.7-69.2) 13078 67.7 (67.0-68.3)
    Weekend 914 27.8 (26.3-29.4) 3991 24.9 (24.2-25.6) 4905 25.4 (24.8-26.0)
    Missing 268 8.2 (7.3-9.1) 1070 6.7 (6.3-7.1) 1338 6.9 (6.6-7.3)
Emergency Severity Index
    1-2 348 10.6 (9.6-11.7) 2070 12.9 (12.4-13.4) 2418 12.5 (12.1-13.0)
    3-5 2259 68.8 (67.2-70.4) 9227 57.5 (56.8-58.3) 11486 59.5 (58.8-60.1)
    Missing 677 20.6 (19.3-22.0) 4740 29.6 (28.9-30.3) 5417 28.0 (27.4-28.7)
First Reported Pain Score
    0-6 437 13.3 (12.2-14.5) 2463 15.4 (14.9-15.9) 2900 15.1 (14.5-15.5)
    >6 1527 46.5 (44.8-48.2) 2984 18.6 (18.0-19.2) 4511 23.3 (22.8-23.9)
    Missing 1320 40.2 (38.5-41.9) 10590 66.0 (65.3-66.8) 11910 61.6 (61.0-62.3)
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Table 2
Ten most common chief complaints and primary discharge diagnoses for patients who were discharged with 
an opioid pain reliever for the treatment of pain
Chief Complaints N (%) Diagnoses N (%)
Traumatic extremity pain 464 (14.2) Musculoskeletal back pain 335 (10.2)
Abdominal pain 409 (12.5) Abdominal pain 330 (10.1)
Back pain 329 (10.1) Extremity fracture 232 (7.1)
Atraumatic extremity pain 295 (9.0) Extremity sprain 213 (6.5)
Motor vehicle accident 224 (6.8) Dental/oral issue 205 (6.2)
Dental complaint 192 (5.9) Other extremity pain 190 (5.8)
Fall 147 (4.5) Nephrolithiasis 147 (4.5)
Flank pain 146 (4.5) Skin contusion 126 (3.9)
Chest pain 107 (3.3) Chest pain (inc. non-cardiac) 108 (3.3)
Headache 97 (3.0) Closed head injury 99 (3.0)
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Table 3
Characteristics of opioid pain reliever prescriptions from the emergency department
strength # of prescriptions (% total) # pills per prescription mean (SD)*
oxycodone
(n = 1716, 52.3% of total) 2.5 mg 1 (<0.1%) 18 (N/A)
5 mg 1680 (97.9%) 15.7 (7.1)
7.5 mg 3 (0.2%) 13.0 (4.2)
10 mg 28 (1.6%) 16.3 (6.8)
15 mg 1 (<0.1%) 10 (N/A)
30 mg 3 (0.2%) 13.3 (5.8)
hydrocodone
(n = 1344, 40.9% of total) 5 mg 1192 (88.7%) 17.3 (7.3)
10 mg 104 (7.7%) 20.8 (12.4)
7.5 mg 37 (2.8%) 17.0 (7.8)
suspension 11 (0.8%) N/A
codeine
(n = 159, 4.8% of total) 5 mg 1 (0.6%) 20 (N/A)
10 mg 1 (0.6%) 24 (N/A)
15 mg 3 (1.9%) 30.3 (25.7)
20 mg 6 (3.8%) 19.8 (9.4)
30 mg 137 (86.2%) 18.0 (6.8)
suspension 11 (6.9%) N/A
hydromorphone
(n = 47, 1.4% of total) 1 mg 1 (2.1%) 28 (N/A)
2 mg 41 (87.2%) 17.3 (8.6)
4 mg 3 (6.4%) 22.7 (18.1)
5 mg 2 (4.3%) 15.0 (7.1)
morphine
(n = 14, 0.4% of total) 5 mg 4 (28.6%) 6 (N/A)
10 mg 1 (7.1%) 20 (N/A)
15 mg 8 (57.2%) 37.1 (34.0)
30 mg 1 (7.1%) 20 (N/A)
NB: Other prescriptions accounted for 4 additional prescriptions (3 for methadone, 1 for fentanyl)
*Number of pills per prescription was available for 3118 (94.9%) of patients
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